Navigation Links
Andromeda Biotech: A drug for type 1 diabetes
Date:11/22/2011

The clinical trial was random, regulated, double-blinded and broad-based. The drug was tested on 457 patients, aged 16-45, who had been diagnosed with Type 1 diabetes a short time before joining the trial. The trial took place in around 40 medical centers in Europe, Israel and South Africa. The patients in the trial were randomly assigned to one of two groups: One received the trial drug (DiaPep277) through a subcutaneous injection once every three months, for a period of two years, while the control group was given a placebo in the same way. In addition, all of the patients received insulin as needed to stabilize their glucose levels.

DiaPep277 was invented by Prof. Irun Cohen and his team at the Weizmann Institute of Science. This unique peptide, containing 24 amino acids, is derived from the sequence of the human heat shock protein 60 (Hsp60). The peptide acts by modulating the immune system, preventing the destruction of the pancreatic cells that secrete insulin and preserving their natural function. Treatment of Type 1 diabetes patients with DiaPep277 may have several medical benefits: slowing the deterioration of the diseased tissue, improved metabolic control, a reduction in daily insulin requirements and fewer complications of diabetes.

During the trial, the ability of the patients' pancreas to secrete insulin was tested. From an initial analysis of the results, it appears that the patients treated with the drug for a year or more had significantly higher pancreas function than those in the control group.

From the point of view of safety, no significant differences were found in the incidence of side effects between the treated and control groups.

Additional data on the drug's efficacy and safety were collected and evaluated, and these will be presented in a final report on the trial, which will be completed in several months.

Andromeda Biotech is now planning to conduct another trial, to try to reproduce t
'/>"/>

Contact: Yivsam Azgad
news@weizmann.ac.il
972-893-43856
Weizmann Institute of Science
Source:Eurekalert

Page: 1 2

Related biology news :

1. Vegetarian diet, physical activity protect against diabetes in black population, study shows
2. Animal study suggests that newborn period may be crucial time to prevent later diabetes
3. VTT identified specific bacteria which precede autoimmune diabetes
4. Joslin study finds clue to birth defects in babies of mothers with diabetes
5. Powerful antibody-based strategy suggests a new therapeutic approach to diabetes and obesity
6. Pitt team identifies key protein causing excess liver production of glucose in diabetes
7. Discovery of insulin switches in pancreas could lead to new diabetes drugs
8. Clues to finding further causes for monogenic diabetes
9. MU study links inactivity with risk factors for Type 2 diabetes
10. Joslin researchers identify new target for treatment of type 2 diabetes and prediabetes
11. How fatty diets cause diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/7/2014)... by Dr. Debra Auguste, associate professor, biomedical engineering, ... City College of New York, have identified a ... one of the most aggressive forms of breast ... a high mortality rate owing to aggressive proliferation ... options. However, Professor Auguste,s team, discovered the overexpression ...
(Date:11/6/2014)... groundbreaking paper from a team of Florida State University ... plants could adapt to and survive environmental swings such ... the latest issue of the journal The Plant ... of DNA and proteins) is organized in a cell ... genes are turned on and others are turned off. ...
(Date:11/6/2014)... Insilico Medicine, Inc, a Baltimore-based bioinformatics company focused ... announced a research collaboration with the international leader ... (OTC: CSBR). , "There are many companies utilizing ... Oncology,s TumorGraft technology is unique in a way ... generating vast amounts of valuable data. Our bioinformatic ...
Breaking Biology News(10 mins):Maize analysis yields whole new world of genetic science 2Insilico Medicine, Inc announces research collaboration with Champions Oncology, Inc 2
... from the U.S. Armed Forces, as well as federal, ... first-responder personnel from throughout the United States, and defense ... 2009 Force Protection Equipment Demonstration (FPED VII). The event ... Corps Base, Quantico, VA, during May 19-21.The demonstration, which ...
... High Volume Transaction Solution Enabling Paperless Processing for ... May 11 Communication Intelligence Corporation (" CIC ... of electronic signature solutions for business process automation ... in biometric signature verification and Striata, the leading ...
... Paperless eCharging Saves Time and Increases EfficiencyWALL, ... (OTC Bulletin Board: BKYI), a leader in ... solutions, today announced that Minnesota counties are ... part of a new paperless criminal charging, ...
Cached Biology News:Demonstration Features Commercial Technology for Combating Terrorism 2Striata and CIC Launch Integrated eSignature, eDelivery, and eBilling for the Financial Services Industry 2Striata and CIC Launch Integrated eSignature, eDelivery, and eBilling for the Financial Services Industry 3Striata and CIC Launch Integrated eSignature, eDelivery, and eBilling for the Financial Services Industry 4Striata and CIC Launch Integrated eSignature, eDelivery, and eBilling for the Financial Services Industry 5Minnesota Counties Secure New Criminal Charging System With BIO-key(R) Fingerprint Biometrics 2Minnesota Counties Secure New Criminal Charging System With BIO-key(R) Fingerprint Biometrics 3
(Date:11/21/2014)... 2014 Deep Research Report on Global ... report on the transformer market. The report provides ... industry chain structure as well as industry overview. ... China’s domestic market as well as global industry ... The report also covers information on policy, plans ...
(Date:11/21/2014)... 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today ... September 30, 2014.  Biorem,s complete 2014 third quarter financial statements and ... Financial Summary:Three-months ended September 30, , Nine-months ended ... , 2014 , 2013 , 2014 ... 5,281 , 6,715 , 14,476 Gross profit ...
(Date:11/18/2014)... 17, 2014 pH measurement and control ... the pharmaceutical, chemical, and food and beverage industries. But ... and how do pH sensors work? METTLER TOLEDO has ... in process industries with these questions and more. , ... in the process industries. The actual sensor, the pH ...
(Date:11/18/2014)... FL (PRWEB) November 18, 2014 Brothers ... announced the launch of PAWSitively Curing Cancer, Inc ... This new 501(c) (3) non-profit organization is dedicated to ... donated goes directly to the University of Florida ... partner with PAWSitively Curing Cancer as the recipient of ...
Breaking Biology Technology:International Transformer Industry - Analysis on Applications, Development & Forecasts Now Available at ReportsnReports.com 2International Transformer Industry - Analysis on Applications, Development & Forecasts Now Available at ReportsnReports.com 3Biorem Reports Third Quarter Results 2Biorem Reports Third Quarter Results 3pH Guide from METTLER TOLEDO Explains Measurement, Theory and Practice of pH Applications 2PAWSitively Curing Cancer, Inc. Launched By Two Children for National Pet Cancer Awareness Month 2PAWSitively Curing Cancer, Inc. Launched By Two Children for National Pet Cancer Awareness Month 3
... 2, 2011 This September, during Prostate Cancer Awareness ... cancer screening method that may change the face of ... Cleveland hospitals and one Boston hospital, analyzed by the National ... urine screening. Dr. David Samadi, Vice Chairman, Department of ...
...  Sept. 2, 2011  PTC Therapeutics, Inc. and ... of their collaboration. Under the original agreement, PTC ... and Genzyme held commercial rights in all other ... rights to ataluren and Genzyme retains an option ...
... This release is available in German . ... and MIT professor Ron Weiss have successfully incorporated a ... recognizes certain cancer cells using logic combinations of five ... (Kobi) Benenson, Professor of Synthetic Biology at ETH Zurich, ...
Cached Biology Technology:More Precise Prostate Cancer Screening on Horizon 2More Precise Prostate Cancer Screening on Horizon 3PTC Therapeutics and Genzyme Announce Restructuring of Collaboration 2PTC Therapeutics and Genzyme Announce Restructuring of Collaboration 3Profiler at the cellular level 2Profiler at the cellular level 3
... 2010 Class II Biological Safety Cabinets ... of comfort while incorporating the latest ... operator, environment and product protection with ... recirculated air.,Bottom filters are safely exchanged ...
... latest SpeedVac Concentrator, the SPD series takes ... new modern twist., The SPD121P SpeedVac comes ... for optimizing runs; preventing samples from freezing; ... at the end-users preset level., Standard features ...
... Oven with circular clear acrylic chamber for ... HybriCycler Oven features microprocessor operation for precise ... the unit., Carousel rotates at 11 ... ,easily removable , Bottle Capacity - ...
... KingFisher magnetic particle based purification systems provide ... from any sample. They offer increased throughput ... three systems- KingFisher, KingFisher mL and KingFisher ... 1000 l. Each system consists of an ...
Biology Products: